Trademark: 90807748
Word
IMBYODIF
Status
Dead
Status Code
605
Status Date
Tuesday, December 28, 2021
Serial Number
90807748
Mark Type
4000
Filing Date
Thursday, July 1, 2021
Published for Opposition
Tuesday, September 14, 2021
Abandoned Date
Tuesday, December 28, 2021

Trademark Owner History
Summit Therapeutics Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions for the treatment of Clostridioides difficile infection; Pharmaceutical formulations for the treatment of Clostridioides difficile infection; Antibiotics

Trademark Events
Dec 28, 2021
Abandonment Notice E-Mailed - After Publication
Dec 28, 2021
Abandonment - After Publication
Dec 20, 2021
Teas Express Abandonment Received
Oct 1, 2021
Extension Of Time To Oppose Received
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Published For Opposition
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 11, 2021
Approved For Pub - Principal Register
Aug 10, 2021
Examiner's Amendment Entered
Aug 10, 2021
Notification Of Examiners Amendment E-Mailed
Aug 10, 2021
Examiners Amendment E-Mailed
Aug 10, 2021
Examiners Amendment -Written
Aug 5, 2021
Assigned To Examiner
Aug 5, 2021
Assigned To Examiner
Aug 5, 2021
Petition To Director - Make Special - Granted
Aug 5, 2021
New Application Office Supplied Data Entered In Tram
Aug 3, 2021
Assigned To Petition Staff
Jul 30, 2021
Teas Petition To Director-Make Special-Received
Jul 5, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24